PPT-Biosimilars: Regulation and Litigation
Agenda Key Regulatory Exclusivities for Biologics Additional Regulatory Exclusivities Patent Strategy for Biologics Comparison Between the 262k Pathway and the ANDA
Download Presentation
"Biosimilars: Regulation and Litigation" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.